Form 4 for KMTS KESTRA MEDICAL TECHNOLOGIES, LTD.
Accepted 2025-07-21 00:00:00 ET · period of report 2025-07-17 · accession 0000950170-25-097321 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-07-21 | 2025-07-17 | KMTS | Mahboob Vaseem | CFO | A - Grant | $0.00 | +22.1K | 36.9K | +149% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Shares | 2025-07-17 | A | A | 22,059 | $0.00 | 36,897 | D | — | — | (F1) Represents restricted stock units ("RSU") that entitle the Reporting Person to receive, at settlement, one common share of Kestra Medical Technologies, Ltd. Subject to the Reporting Person's continued service, the RSUs will vest 7,353 on July 17, 2026, 7,353 on July 17, 2027 and 7,354 on July 17, 2028. |